Reuters logo
BRIEF-Boai NKY Pharmaceuticals to acquire U.S. firm BioVision for up to $290 mln
2017年6月7日 / 上午10点17分 / 5 个月前

BRIEF-Boai NKY Pharmaceuticals to acquire U.S. firm BioVision for up to $290 mln

June 7 (Reuters) - Boai NKY Pharmaceuticals Ltd

* Says it plans to acquire U.S. biotechnology firm Biovision Inc for up to $290 million

Source text in Chinese: bit.ly/2rAjekE

Further company coverage: (Reporting by Hong Kong newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below